What does Anorel do?
ANOREL specializes in the development and manufacture of innovative pharmaceutical products. The company focuses on creating solutions that enhance patient care and improve health outcomes. With a commitment to research and quality, ANOREL aims to address unmet medical needs in various therapeutic areas.
- Sectors
- Consultancy firms Wholesalers
- Signals
-
ProfitableProfitable € 520K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.04MStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 277KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 636KPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 24.65MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 14.0%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
24.65M
|
€
20.93M
|
€
25.94M
|
€
18.65M
|
|
|
€
636K
|
€
479K
|
€
897K
|
€
762K
|
|
|
€
161K
|
€
52K
|
€
238K
|
€
183K
|
|
|
€
3.04M
|
€
2.88M
|
€
2.83M
|
€
1.85M
|
|
|
19.20%
|
25.77%
|
24.73%
|
16.87%
|
|
|
€
12.79M
|
€
8.29M
|
€
8.60M
|
€
9.10M
|
|
|
€
752K
|
€
1.37M
|
€
714K
|
€
738K
|
|
|
15.50
|
13
|
14
|
15.60
|
Publications 31
All publications- Ontslagen - Benoemingen 23/01/2026
- Ontslagen - Benoemingen 28/05/2025
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Doel - Ontslagen - Benoemingen - Algemene Vergadering 01/04/2025
- Ontslagen - Benoemingen 28/10/2022
- Ontslagen - Benoemingen 28/03/2022
Frequently asked questions
Answers to the most common questions about Anorel, based on official government data and the filed annual accounts.
What is the VAT number of Anorel?
The VAT number of Anorel is BE0472.483.535.
How many employees work at Anorel?
In 2025, Anorel employed 15.50 full-time equivalents (FTE).
When was Anorel established?
Anorel was founded in 26-07-2000.
What is the official address of Anorel?
The official address of Anorel is Lintsesteenweg 632 Hove 2540.
What is the legal form of Anorel?
The juridical form of Anorel is Public limited company (NV/SA).
What is the annual revenue of Anorel?
The revenue of Anorel for the 2025 financial year was €24,651,912.
What does Anorel do?
ANOREL specializes in the development and manufacture of innovative pharmaceutical products. The company focuses on creating solutions that enhance patient care and improve health outcomes. With a commitment to research and quality, ANOREL aims to address unmet medical needs in various therapeutic areas.
Is Anorel a reliable company?
Anorel is a registered Rechtspersoon with company number 0472.483.535 and can be verified through the official CBE database.
What is the credit limit of Anorel?
The estimated credit limit of Anorel is €1,396,691.
Is Anorel still active?
Anorel currently has the status "Normal situation" and is active.